Mood Disorders News

PHILADELPHIA — Primary care patients with depression and anxiety symptoms utilized and benefited from a computerized cognitive behavioral therapy program, according to data presented at the Anxiety and Depression Association of America annual conference.

PHILADELPHIA — Rochelle Caplan, MD, of the University of California, Los Angeles, discusses conversion disorder in children and adolescents, comorbid anxiety disorders and depression, diagnostic challenges and treatment.

PHILADELPHIA — Anxiety and related disorders were significantly more common among sexual minority young adults than heterosexual peers, and stressors such as sexual orientation concealment and community attitudes were associated with disorders, according to data presented here.

LGBTQ individuals are approximately three times more likely to experience a mental health disorder, such as depression or generalized anxiety disorder, compared with other individuals, according to the National Alliance on Mental Illness.

Recent findings provide further evidence of an association between Toxoplasma gondii and aggression.

The FDA is requiring a boxed warning about the risks of opioid abuse, misuse, overdose, addiction and death for immediate-release opioid pain medication, according to a press release.

Findings from a large observational study indicated no significant associations between selective serotonin reuptake inhibitors and increased risk for arrhythmia, myocardial infarction or stroke/transient ischemic attack in adults with depression.

Recent findings indicated different neural mechanisms associated with irritability between youth with disruptive mood dysregulation disorder and peers with bipolar disorder.

Allergan recently announced that Vraylar, a once-daily oral atypical antipsychotic, is now available by prescription in pharmacies throughout the United States.

Recent findings indicated significant heterogeneity in course trajectories of moderate-to-severe major depressive disorder, with many individuals not receiving additional treatment 2 years after diagnosis.